Open AccessQT prolongation risk with antiemetics during COVID 19 treatment
Author(s) -
Aksoy Nilay,
Sancar Mesut
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14041
Subject(s) - medicine , qt interval , nausea , vomiting , torsades de pointes , intensive care medicine , cardiotoxicity , adverse effect , anesthesia , hydroxychloroquine , antiemetic , azithromycin , covid-19 , disease , infectious disease (medical specialty) , chemotherapy , antibiotics , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom